Yüklüyor......
The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia
BACKGROUND: In Australia, government-subsidised access to high-cost medicines is "targeted" to particular sub-sets of patients under the Pharmaceutical Benefits Scheme to achieve cost-effective use. In order to determine how this access system could be improved, the opinions of key stakeho...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2231358/ https://ncbi.nlm.nih.gov/pubmed/18096055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-8462-4-26 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|